Reported Oct 5, 2016 · Terminated

Lamotrigine Tablets, USP, 150 mg, 500-count Tablets per bottle, Rx only, Manufactured by

Unichem Pharmaceuticals USA Inc.

Low riskThis product is unlikely to cause harm, but it breaks a safety or labelling rule.

What you should do

Stop using the affected lot and contact the recalling firm for the return or refund process. Check the FDA enforcement report for lot-level detail.

Firm contact: Unichem Pharmaceuticals Usa Inc · 777 Terrace Ave · Hasbrouck Heights, NJ · 07604-3102

Is this the product you have?

Lamotrigine Tablets, USP, 150 mg, 500-count Tablets per bottle, Rx only, Manufactured by

3 of 3 products

Products covered by this recall
#Product as published
1Unichem Laboratories LTD., Pilerne Ind. Estate, Pilerne, Bardez, Goa 403 511 India
2Marketed by: Unichem Pharmaceuticals (USA), Inc ., Rochelle Park, NJ 07662
3NDC 29300-113-05.
Lot codes and dates
    • Lot #: GLEH 16003
    • Exp 03/31/18
Amount recalled
368 bottles

Where it was sold

  • Nationwide

Why it was recalled

Tablets/Capsules Imprinted With Wrong ID: incorrect imprint debossed on the tablets.

This product is unlikely to cause harm, but it breaks a safety or labelling rule.

Want the full recall guide?

The guide adds the identifying codes laid out for scanning, symptoms to watch for, a timeline, and news coverage of this recall.

Free recall alerts

Get alerted about new Unichem Pharmaceuticals USA Inc. recalls

One email when a matching recall is published. No account, no cost, unsubscribe in one click.

Where this came from

Source: U.S. Food & Drug Administration (openFDA)

Read the FDA (openFDA drug enforcement) notice

Notice updated Feb 7, 2017 · Data as of Sep 19, 5:01 PM UTC

RecallNow is not a government agency. Every fact on this page is published by the FDA, USDA or CPSC and links back to their notice.